| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: LEMTRADA (Campath, alemtuzumab) | |
| ***************************************************** | |
| #Post#: 2711-------------------------------------------------- | |
| (Abst.) Alemtuzumab-induced lung injury in 3 MS patients | |
| By: agate Date: November 3, 2019, 11:27 pm | |
| --------------------------------------------------------- | |
| From PubMed (November 2, 2019), "Alemtuzumab-induced lung injury | |
| in multiple sclerosis: Learning from adversity in three | |
| patients": | |
| https://www.ncbi.nlm.nih.gov/pubmed/31675637 | |
| ***************************************************** |